Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Life Health > Health Insurance

Researchers show Alzheimer’s slime fights infections

X
Your article was successfully shared with the contacts you provided.

Researchers have shown that amyloid beta, a slimy substance found in the brains of people with Alzheimer’s disease, protects living mice and cultured human brain cells against brain infections.

The research could help speed up the search for methods for preventing or curing Alzheimer’s.

See also: Some projected net health insurance costs go poof

Scientists have been speculating for years that infections and the immune system might have something to do with Alzheimer’s. 

Deepak Kumar and other scientists at Massachusetts General Hospital tested that idea in the lab by creating mice that were unable to produce amyloid beta. The scientists showed that the mice that could produce amyloid beta had a much easier time fighting off salmonella infections and yeast infections in the brain.

The scientists conducted a similar experiment using yeast, cultured human brain cells, and amyloid from the brains of people with Alzheimer’s disease.

Genuine amyloid protected the human brain cells against the yeast infection, and it was about 1,000 times more effective than a synthetic version of amyloid, the researchers say.

Other research has implied that some people may develop Alzheimer’s disease because, or partly because, they have a gene that interferes with the body’s effort to clear old amyloid out of the brain.

The results of the new research suggest that finding and controlling any microbes that cause the brain to produce amyloid might be a good way to fight Alzheimer’s, according to researchers.

The researchers say another good strategy might be to fine-tune amyloid production, for example, to set it high enough to fight infections but low enough to keep brain cells healthy. 

See also: 

What advisors should know about a new Alzheimer’s research report

LTCI Watch: Autoimmune

  

Are you following us on Facebook?


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.